BACKGROUND: Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive tubular disease caused by mutations in the CLDN16 or CLDN19 gene. Previous studies using microsatellite markers flanking the CLDN19 locus estimated that p.G20D (c.59G>A), a recurrent mutation in Spanish families, is a founder mutation. In the present study, we assessed the haplotype of Spanish patients using single nucleotide polymorphisms (SNPs). METHODS: Twenty-seven FHHNC patients were included in this study. We analyzed four SNPs located in CLDN19 introns 3 and 4 by polymerase chain reaction amplification and DNA sequencing. RESULTS: Three new patients with homozygous p.G20D were identified. The SNP genotyping analysis showed that alleles carrying this mutation shared a common SNP haplotype. CONCLUSIONS: Our findings suggest the existence of a founder effect responsible for FHHNC in our cohort. Testing for the presence of mutation p.G20D should be the first genetic screening in Spanish patients.
BACKGROUND:Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is an autosomal recessive tubular disease caused by mutations in the CLDN16 or CLDN19 gene. Previous studies using microsatellite markers flanking the CLDN19 locus estimated that p.G20D (c.59G>A), a recurrent mutation in Spanish families, is a founder mutation. In the present study, we assessed the haplotype of Spanish patients using single nucleotide polymorphisms (SNPs). METHODS: Twenty-seven FHHNC patients were included in this study. We analyzed four SNPs located in CLDN19 introns 3 and 4 by polymerase chain reaction amplification and DNA sequencing. RESULTS: Three new patients with homozygous p.G20D were identified. The SNP genotyping analysis showed that alleles carrying this mutation shared a common SNP haplotype. CONCLUSIONS: Our findings suggest the existence of a founder effect responsible for FHHNC in our cohort. Testing for the presence of mutation p.G20D should be the first genetic screening in Spanish patients.
Authors: V Benigno; C S Canonica; A Bettinelli; R O von Vigier; A C Truttmann; M G Bianchetti Journal: Nephrol Dial Transplant Date: 2000-05 Impact factor: 5.992
Authors: Martin Konrad; Andre Schaller; Dominik Seelow; Amit V Pandey; Siegfried Waldegger; Annegret Lesslauer; Helga Vitzthum; Yoshiro Suzuki; John M Luk; Christian Becker; Karl P Schlingmann; Marcel Schmid; Juan Rodriguez-Soriano; Gema Ariceta; Francisco Cano; Ricardo Enriquez; Harald Juppner; Sevcan A Bakkaloglu; Matthias A Hediger; Sabina Gallati; Stephan C F Neuhauss; Peter Nurnberg; Stefanie Weber Journal: Am J Hum Genet Date: 2006-09-19 Impact factor: 11.025
Authors: Stefanie Weber; Linda Schneider; Melanie Peters; Joachim Misselwitz; Gabriele Rönnefarth; Michael Böswald; Klaus E Bonzel; Tomas Seeman; Tereza Suláková; Eberhard Kuwertz-Bröking; Alojz Gregoric; Jean-Bernard Palcoux; Velibor Tasic; Friedrich Manz; Karl Schärer; Hannsjörg W Seyberth; Martin Konrad Journal: J Am Soc Nephrol Date: 2001-09 Impact factor: 10.121
Authors: A Blanchard; X Jeunemaitre; P Coudol; M Dechaux; M Froissart; A May; R Demontis; A Fournier; M Paillard; P Houillier Journal: Kidney Int Date: 2001-06 Impact factor: 10.612
Authors: Jianghui Hou; Aparna Renigunta; Antonio S Gomes; Mingli Hou; David L Paul; Siegfried Waldegger; Daniel A Goodenough Journal: Proc Natl Acad Sci U S A Date: 2009-08-24 Impact factor: 11.205
Authors: Jianghui Hou; Aparna Renigunta; Martin Konrad; Antonio S Gomes; Eveline E Schneeberger; David L Paul; Siegfried Waldegger; Daniel A Goodenough Journal: J Clin Invest Date: 2008-02 Impact factor: 14.808
Authors: Félix Claverie-Martín; Víctor García-Nieto; Cesar Loris; Gema Ariceta; Inmaculada Nadal; Laura Espinosa; Ángeles Fernández-Maseda; Montserrat Antón-Gamero; Africa Avila; Álvaro Madrid; Hilaria González-Acosta; Elizabeth Córdoba-Lanus; Fernando Santos; Marta Gil-Calvo; Mar Espino; Elena García-Martinez; Ana Sanchez; Rafael Muley Journal: PLoS One Date: 2013-01-03 Impact factor: 3.240